c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
NervGen Pharma (NGEN) Reports Narrower Loss but Rising Net Deficit Amid R&D Spend Surge
GuruFocus | Nov 16, 2026 7:59 AM EST
Related Stocks: NGEN ,
Read original article